Study of Escitalopram in the Treatment of Specific Phobia

Status Completed

Clinical Trial Summary

This pilot study is designed to assess the efficacy of escitalopram in the treatment of specific phobia in adult outpatients.

Clinical Trial Description

This double-blind placebo-controlled pilot trial study is designed to assess the efficacy of 12 weeks of escitalopram vs. placebo in the treatment of specific phobia in adult outpatients. It is hypothesized that escitalopram is safe and effective in the treatment of specific phobia. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Phobic Disorders

Clinical Trial Details

NCT number	NCT00121069
Study type	Interventional
Source	Connor, Kathryn M., M.D.
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	September 2002
Completion date	September 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01963806` - ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder	N/A
Recruiting	`NCT03653923` - Neurophysiological Correlates of Exposition Therapy in Spider Phobia	N/A
Completed	`NCT00184106` - RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo	Phase 4
Completed	`NCT00051220` - Treatment for Specific Phobias in Children	Phase 1/Phase 2
Completed	`NCT02310152` - Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)	N/A
Completed	`NCT02387047` - Validity of a Self-administered Questionnaire to Screen Phobia of Falling in the Elderly	N/A
Completed	`NCT00000370` - Treatment of Social Phobia	N/A
Completed	`NCT03012035` - The Role of Treatment Expectation in Exposure Training With Spider Fearful Participants	N/A
Completed	`NCT02007694` - Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants	Phase 2/Phase 3
Active, not recruiting	`NCT03188575` - Effectiveness & Cost-effectiveness of Internet-delivered Interventions for Depression and Anxiety Disorders in IAPT	N/A
Completed	`NCT02432703` - A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder	Phase 2
Terminated	`NCT01574014` - Glucocorticoid Treatment for Social Phobia	Phase 2
Completed	`NCT00734422` - Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants	Phase 2/Phase 3
Not yet recruiting	`NCT02336802` - Threat-Avoidance Learning in Anxiety Patients	N/A
Completed	`NCT01361074` - In Vivo Versus Augmented Reality Exposure for Small Animal Phobia	N/A
Completed	`NCT00104195` - A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions	Phase 1
Completed	`NCT00035412` - St. John's Wort Versus Placebo in Social Phobia	Phase 2
Completed	`NCT00128401` - Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia	Phase 2
Recruiting	`NCT02020824` - Virtual Reality and Concept of Control in the Treatment of Acrophobia	N/A
Terminated	`NCT01623583` - Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias	Phase 4